...
机译:成年患者的复发或难治性弥漫性大型B细胞淋巴瘤的持续疾病控制:朱丽叶的更新分析,Tisagenlecleel的全球枢轴阶段2试验
Univ Penn Abramson Canc Ctr Lymphoma Program Philadelphia PA 19104 USA;
Univ Chicago Med Hematopoiet Cellular Therapy Program Chicago IL USA;
St Vincents Hosp Melbourne Vic Australia;
Univ Hosp Cologne Dept Haematol &
Oncol Cologne Germany;
Med Univ Vienna Div Hematol &
Hemostaseol Dept Internal Med 1 Vienna Austria;
Emory Univ Winship Canc Inst Bone Marrow &
Stem Cell Transplant Ctr Atlanta GA 30322 USA;
Oslo Univ Hosp Oslo Norway;
Univ Kansas Med Ctr Dept Blood &
Bone Marrow Transplant Kansas City KS 66103 USA;
James Canc Hosp Columbus OH USA;
Natl Canc Ctr Dept Hematol Tokyo Japan;
Univ Calif San Francisco Helen Diller Family Comprehens Canc Ctr Dept Hematol &
Blood &
Marrow;
Maisonneuve Rosemont Hosp Montreal PQ Canada;
Wurzburg Univ Med Ctr Ctr Allogene Stem Cell Transplantat Wurzburg Germany;
Hokkaido Univ Grad Sch Med Dept Hematol Sapporo Hokkaido Japan;
Univ Texas MD Anderson Canc Ctr Div Canc Med Dept Lymphoma &
Myeloma Houston TX 77030 USA;
Univ Minnesota Div Hematol Oncol &
Transplantat Minneapolis MN USA;
McMaster Univ Juravinski Hosp &
Canc Ctr Hamilton ON Canada;
Royal Prince Alfred Hosp Sydney NSW Australia;
Univ Michigan Comprehens Canc Ctr Ann Arbor MI 48109 USA;
Johns Hopkins Univ Sidney Kimmel Comprehens Canc Ctr Baltimore MD USA;
Kyushu Univ Grad Sch Med Sci Dept Med &
Biosyst Sci Fukuoka Fukuoka Japan;
Univ Amsterdam Acad Med Ctr Dept Hematol Amsterdam Netherlands;
Weill Cornell Med NewYork Presbyterian Hosp Div Hematol &
Oncol New York NY USA;
Novartis Pharmaceut E Hanover NJ USA;
Novartis Pharma AG Basel Switzerland;
Novartis Pharma AG Basel Switzerland;
Univ Lyon Hosp Civils Lyon Dept Hematol Lyon France;
Oregon Hlth &
Sci Knight Canc Inst Ctr Hematol Malignancies Portland OR USA;
机译:成年患者的复发或难治性弥漫性大型B细胞淋巴瘤的持续疾病控制:朱丽叶的更新分析,Tisagenlecleel的全球枢轴阶段2试验
机译:在朱丽叶研究中用Tisagenleclecel处理的复发或难治弥漫性大B细胞淋巴瘤(R / R DLBCL)的成人患者中细胞因子释放综合征(CRS)的共识分级
机译:患者报告的患者在儿童和年轻成人中输注后的患者的生活质量,复发或难治性B细胞急性淋巴细胞白血病:全球性,单臂,第2期试验
机译:弥漫性大B细胞淋巴瘤与中枢神经系统复发的突变特征:用于癌症基因组学数据库的CBioPortal分析
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:输注时无可测疾病的复发/难治性弥漫性大B细胞淋巴瘤患者中的Tisagenlecleucel
机译:成人患者的Tisagenlecleucel在复发或难治性弥漫性大B细胞淋巴瘤中的长期随访:朱丽叶研究的更新分析